Cargando…
Safety and Efficacy of Extremely Low LDL-Cholesterol Levels and Its Prospects in Hyperlipidemia Management
The risk of cardiovascular disease has been reported to have a linear relationship with LDL levels. Additionally, the currently recommended LDL target goal of 70 mg/dl does not diminish the CV risk entirely leaving behind some residual risk. Previous attempts to maximally lower the LDL levels with s...
Autores principales: | Bandyopadhyay, Dhrubajyoti, Qureshi, Arshna, Ghosh, Sudeshna, Ashish, Kumar, Heise, Lyndsey R., Hajra, Adrija, Ghosh, Raktim K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937425/ https://www.ncbi.nlm.nih.gov/pubmed/29850255 http://dx.doi.org/10.1155/2018/8598054 |
Ejemplares similares
-
Cardiovascular Outcomes of PCSK9 Inhibitors: With Special Emphasis on Its Effect beyond LDL-Cholesterol Lowering
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2018) -
Novel imaging modalities to predict the development of atrial fibrillation post stroke
por: Faisaluddin, Mohammed, et al.
Publicado: (2018) -
Effects of inflammatory bowel disease on in-hospital outcomes in patients with congestive heart failure: A retrospective national inpatient sample study
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2019) -
Association between direct-acting oral anticoagulants vs. warfarin with the risk of osteoporosis in patients with non-valvular atrial fibrillation
por: Akhtar, Tauseef, et al.
Publicado: (2020) -
Impact of atrial fibrillation in patients with lung cancer: Insights from National Inpatient Sample
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2019)